HemaCare Corporation: Hemacare Reports 18% Increase in Revenue and 52% Increase in Net Income in Third Quarter 2006
15th Nov 2006, 00:33 GMT
LOS ANGELES, CA (MARKET WIRE) HemaCare Corporation (OTCBB: HEMA) today announced third quarter 2006 results of operations that resulted in an 18% increase in revenue from the same period of 2005, and a 52% increase in net income to $448,000, or $0.05 per share basic and diluted, marking the Company's twelfth consecutive profitable quarter. The Company generated $9.2 million in revenue during the quarter, up from $7.8 million reported
HemaCare Corporation: Hemacare Reports 18% Increase in Revenue and 52% Increase in Net Income in Third Quarter 2006 related news:
- Continental Materials Corporation: Continental Materials Corporation Reports Third Quarter Results — Market Wire - Earnings Reports
- Netsmart Reports Q3 2006 Results — StratWire - Business of Healthcare NewsFeed
- First Federal Bancshares, Inc.: First Federal Bancshares, Inc. Announces 3rd Quarter Earnings — Market Wire - Financial Services
- Varsity Group Inc.: Varsity Group Inc. Reports Third Quarter Results — Market Wire - Computers and Software
- Astro-Med, Inc.: Astro-Med Reports Record Third Quarter Earnings; Directors Declare Regular Cash Dividend — Market Wire - Computers and Software
- RWE net income surges 23% — Energy Business Review Latest News
- Giant Industries reports $3 per share net income in Q3 — bizjournals.com Energy:Oil & Gas headlines
- SpaceDev, Inc.: SpaceDev Reports Third Quarter Fiscal 2006 Results — Market Wire - Earnings Reports
- Viscount Systems Inc.: Viscount Reports Q3 2006 Results — Market Wire - Telecom
- Ocean Bio-Chem Inc.: Ocean Bio-Chem Profit Increase Jumps at Nine Months Ending September 30, 2006 — Market Wire - Earnings Reports
Latest news from Market Wire - Medical and Healthcare:
- slp3D: ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Precise Biometrics AB: Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Lenstec, Inc.: Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL
- Takeda Pharmaceuticals North America: New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients With Type 2 Diabetes
- Dairy Fresh Farms Inc.: Dairy Fresh Farms Announces It Has Signed a Licensing Deal With NutriOne for the Canadian Market
- OTSP: Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)
- Vue Technology: Vue Technology Introduces First UHF Solution for Item-Level Visibility in the Retail Pharmacy; New RFID Solution Tracks Liquids, Pill Bottles, Blister Packs and Gels
- Union Dental Holdings, Inc.: Union Dental Signs Contract to Provide Dental Network for United Association of Plumbers and Pipefitters
- MEDSEEK: MEDSEEK, SelfCareNet, & Primetime Medical Partner to Deliver Integrated Consumer-Centric Solution
- Ridgecrest Healthcare Group, Inc.: Ridgecrest Healthcare Group to Acquire NOBO List